Log in to save to my catalogue

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08a87c1bf95d4f798e9e0d5a7daabd61

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Aggressive cancers often have activating mutations in growth-controlling oncogenes and inactivating mutations in tumor-suppressor genes. In neuroblastoma, amplification of the
MYCN
oncogene and inactivation of the
ATRX
tumor-suppressor gene correlate with high-risk disease and poor prognosis. Here we show that
ATRX
mutations and

Alternative Titles

Full title

MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_08a87c1bf95d4f798e9e0d5a7daabd61

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_08a87c1bf95d4f798e9e0d5a7daabd61

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-020-14682-6

How to access this item